Payment overview · 2025
General Payments
$168.26
9 reported records · 5 companies
Healthcare provider profile · identity verified
Thomas N Epperson, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MIDDLESBORO, KY · NPI 1184605966
Verified facts
What the public records show
CMS Open Payments records show Thomas N Epperson, MD received $168.26 in general payments during 2025 across 9 reported records.
Lilly USA, LLC accounted for 27.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 221 claims for Jardiance by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 48 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $46.57 | 27.7% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $44.53 | 26.5% | 2 | 2025 |
| VERTEX PHARMACEUTICALS INCORPORATED | Unresolved — no canonical attribution shown | $41.10 | 24.4% | 2 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $19.29 | 11.5% | 1 | 2025 |
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $16.77 | 10.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $168.26 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $46.57 | 3 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $46.57 | 3 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $44.53 | 2 | 2025 |
Source payment records
|
|||||
| JOURNAVX Normalized: journavx |
Drug | VERTEX PHARMACEUTICALS INCORPORATED | $41.10 | 2 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $19.29 | 1 | 2025 |
Source payment records
|
|||||
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $16.77 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
221 | 27 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
48 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 648 | 106 |
| Amlodipine Besylate | Amlodipine Besylate | 445 | 76 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 408 | 53 |
| Lisinopril | Lisinopril | 398 | 71 |
| Levothyroxine Sodium | Levothyroxine Sodium | 387 | 72 |
| Losartan Potassium | Losartan Potassium | 333 | 60 |
| Eliquis | Apixaban | 330 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 301 | 40 |
| Famotidine | Famotidine | 281 | 49 |
| Gabapentin | Gabapentin | 240 | 28 |
| Furosemide | Furosemide | 228 | 48 |
| Farxiga | Dapagliflozin Propanediol | 223 | 27 |
| Jardiance | Empagliflozin | 221 | 27 |
| Omeprazole | Omeprazole | 194 | 38 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 192 | 39 |
| Simvastatin | Simvastatin | 182 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 173 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 162 | 27 |
| Donepezil Hcl | Donepezil Hcl | 155 | 22 |
| Metformin Hcl | Metformin Hcl | 153 | 31 |
| Sertraline Hcl | Sertraline Hcl | 153 | 25 |
| Alprazolam | Alprazolam | 152 | 23 |
| Hydralazine Hcl | Hydralazine Hcl | 152 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 151 | 25 |
| Carvedilol | Carvedilol | 145 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 145 | 30 |
| Fluticasone Propionate | Fluticasone Propionate | 141 | 48 |
| Potassium Chloride | Potassium Chloride | 139 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 139 | 23 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 138 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 123 | 22 |
| Alendronate Sodium | Alendronate Sodium | 121 | 23 |
| Atenolol | Atenolol | 115 | 16 |
| Ezetimibe | Ezetimibe | 111 | 15 |
| Trazodone Hcl | Trazodone Hcl | 108 | 16 |
| Glimepiride | Glimepiride | 100 | 17 |
| Montelukast Sodium | Montelukast Sodium | 95 | 23 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 93 | 15 |
| Januvia | Sitagliptin Phosphate | 88 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 84 | 15 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 84 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 83 | 16 |
| Memantine Hcl | Memantine Hcl | 83 | suppressed |
| Nitroglycerin | Nitroglycerin | 80 | 17 |
| Meloxicam | Meloxicam | 78 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 69 | 14 |
| Tramadol Hcl | Tramadol Hcl | 67 | suppressed |
| Valsartan | Valsartan | 63 | suppressed |
| Celecoxib | Celecoxib | 61 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 61 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 59 | suppressed |
| Constulose | Lactulose | 58 | suppressed |
| Ibuprofen | Ibuprofen | 58 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 58 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 56 | 11 |
| Kapspargo Sprinkle | Metoprolol Succinate | 56 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 55 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 55 | suppressed |
| Linzess | Linaclotide | 53 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 53 | suppressed |
| Allopurinol | Allopurinol | 50 | suppressed |
| Glipizide | Glipizide | 49 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 48 | 18 |
| Ozempic | Semaglutide | 48 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 46 | suppressed |
| Sucralfate | Sucralfate | 45 | suppressed |
| Gemtesa | Vibegron | 44 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 42 | suppressed |
| Brilinta | Ticagrelor | 41 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 41 | suppressed |
| Xarelto | Rivaroxaban | 41 | suppressed |
| Azithromycin | Azithromycin | 40 | 28 |
| Divalproex Sodium | Divalproex Sodium | 40 | suppressed |
| Finasteride | Finasteride | 40 | suppressed |
| Naproxen | Naproxen | 40 | suppressed |
| Vascepa | Icosapent Ethyl | 40 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 39 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 39 | suppressed |
| Mirtazapine | Mirtazapine | 39 | 13 |
| Glipizide Er | Glipizide | 38 | suppressed |
| Levofloxacin | Levofloxacin | 37 | 24 |
| Pregabalin | Pregabalin | 36 | suppressed |
| Clonazepam | Clonazepam | 34 | suppressed |
| Bumetanide | Bumetanide | 32 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 32 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 32 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 31 | suppressed |
| Entresto | Sacubitril/Valsartan | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 30 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 30 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 29 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 18 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 28 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 24 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | suppressed |
| Nystatin | Nystatin | 28 | 11 |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Latanoprost | Latanoprost | 27 | suppressed |
| Prednisone | Prednisone | 26 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 26 | 20 |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Cilostazol | Cilostazol | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 25 | suppressed |
| Spironolactone | Spironolactone | 25 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 25 | suppressed |
| Cromolyn Sodium | Cromolyn Sodium | 24 | suppressed |
| Levemir | Insulin Detemir | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Methylprednisolone | Methylprednisolone | 24 | 12 |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Fluconazole | Fluconazole | 23 | 17 |
| Sotalol | Sotalol Hcl | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 22 | 20 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 20 | 18 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 20 | suppressed |
| Levetiracetam | Levetiracetam | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Carbamazepine | Carbamazepine | 19 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | 13 |
| Bupropion Xl | Bupropion Hcl | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Metolazone | Metolazone | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Desloratadine | Desloratadine | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Ranolazine Er | Ranolazine | 16 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Humulin R | Insulin Regular, Human | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 15 | suppressed |
| Meropenem | Meropenem | 15 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 15 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Motegrity | Prucalopride Succinate | 14 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Dexamethasone | Dexamethasone | 13 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 13 | suppressed |
| Permethrin | Permethrin | 13 | 11 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 12 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 12 | suppressed |
| Galantamine Er | Galantamine Hbr | 12 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 12 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Restasis | Cyclosporine | 12 | suppressed |
| Ssd | Silver Sulfadiazine | 12 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 12 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $168.26 · 9 records | Lilly USA, LLC | Cologuard Collection Kit, JOURNAVX, Korlym, MOUNJARO, Wegovy, ZEPBOUND | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error